ea0049gp70 | Developmental & Protein Endocrinology | ECE2017
Marjot Tom
, Othonos Nantia
, Woods Conor
, Hazlehurst Jonathan
, Moola Ahmad
, Hodson Leanne
, Tomlinson Jeremy
Introduction: Glucocorticoids (GC) are prescribed to 23% of the population of the UK and USA. Their use is associated with a significant side effect profile that includes the development of central obesity, insulin resistance and type 2 diabetes. 5α-reductase (5αR) inhibitors (Finasteride and Dutasteride) are also commonly prescribed in the context of prostate disease, where they inhibit the conversion of testosterone to dihydrotestosterone. Additionally, they ...